Benchmark reissued their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 price objective on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price target on shares of Clene in a research note on Wednesday, […]